Neuromyelitis optica spectrum disorder
Positive new Phase III MRI results from the NMOSD study UPLIZNA
SG Tylor
Source – Horizon Therapeutics Horizon Therapeutics unveiled positive MRI data from a Phase III clinical trial of UPLIZNA (inebilizumab) at ...
